In summary, our systematic analysis of GMRGs screened for GPT as a potential diagnostic and prognostic marker for CRC, revealed the correlation between GPT and the tumor microenvironment, and explored the relationship between GPT expression and sensitivity to common drugs. The gene discussed is GPT; the disease is colorectal carcinoma.